MT PHARMA Trademark

Trademark Overview


On Wednesday, January 20, 2016, a trademark application was filed for MT PHARMA with the United States Patent and Trademark Office. The USPTO has given the MT PHARMA trademark a serial number of 86881499. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 22, 2018. This trademark is owned by Mitsubishi Tanabe Pharma Corporation. The MT PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); neuroprotective medicines; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antiallergic medicines; antihypertensives; hypoglycemic agents; antidiabetic preparations; pharmaceutical preparations for the prevention of diabetic nephropathy; pharmaceutical preparations, namely, antiphlogistic agents; vaccine; pharmaceutical preparations for the treatment of autoimmune disease; pharmaceutical preparations for the treatment of cerebral infarction; pharmaceutical prepar...
mt pharma

General Information


Serial Number86881499
Word MarkMT PHARMA
Filing DateWednesday, January 20, 2016
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, January 22, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"PHARMA"
Goods and ServicesPharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); neuroprotective medicines; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antiallergic medicines; antihypertensives; hypoglycemic agents; antidiabetic preparations; pharmaceutical preparations for the prevention of diabetic nephropathy; pharmaceutical preparations, namely, antiphlogistic agents; vaccine; pharmaceutical preparations for the treatment of autoimmune disease; pharmaceutical preparations for the treatment of cerebral infarction; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of erectile dysfunction

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 26, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMitsubishi Tanabe Pharma Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-8505
JP

Trademark Events


Event DateEvent Description
Monday, January 22, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, January 22, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, June 26, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, June 26, 2017FINAL REFUSAL E-MAILED
Monday, June 26, 2017FINAL REFUSAL WRITTEN
Saturday, June 3, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 1, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 1, 2016NON-FINAL ACTION E-MAILED
Thursday, December 1, 2016NON-FINAL ACTION WRITTEN
Thursday, November 10, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 9, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 9, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 10, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 10, 2016NON-FINAL ACTION E-MAILED
Tuesday, May 10, 2016NON-FINAL ACTION WRITTEN
Wednesday, May 4, 2016ASSIGNED TO EXAMINER
Tuesday, January 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 23, 2016NEW APPLICATION ENTERED IN TRAM